Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proshares Trust (ZBIO) Short-term Investments (2024 - 2025)

Historic Short-term Investments for Zenas BioPharma (ZBIO) over the last 2 years, with Q3 2025 value amounting to $175.3 million.

  • Zenas BioPharma's Short-term Investments rose 19688764.04% to $175.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $175.3 million, marking a year-over-year increase of 19688764.04%. This contributed to the annual value of $31.0 million for FY2024, which is N/A changed from last year.
  • Per Zenas BioPharma's latest filing, its Short-term Investments stood at $175.3 million for Q3 2025, which was up 19688764.04% from $229.3 million recorded in Q2 2025.
  • Zenas BioPharma's 5-year Short-term Investments high stood at $229.3 million for Q2 2025, and its period low was $86000.0 during Q1 2024.